22157.jpg
Worldwide AAV Vector Industry Report 2022 - by Type of Therapy, Type of Gene Delivery Method Used, Target Therapeutic Area, Application Area, Scale of Operation and Geographical Regions
17 oct. 2022 07h08 HE | Research and Markets
Dublin, Oct. 17, 2022 (GLOBE NEWSWIRE) -- The "AAV Vector Market: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering. This report features...
22157.jpg
Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market Report 2022: Increasing Number of Cell & Gene Therapies Priming Sector for Substantial Growth
06 oct. 2022 05h23 HE | Research and Markets
Dublin, Oct. 06, 2022 (GLOBE NEWSWIRE) -- The "Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector, Application...
Global Cell Therapy Market
Outlook on the Cell Therapy Global Market to 2028 - Increased Demand for Novel, Better Medicines for Diseases Such as Cancer and CVD Has Resulted in an Increase in General Research Efforts
05 oct. 2022 07h08 HE | Research and Markets
Dublin, Oct. 05, 2022 (GLOBE NEWSWIRE) -- The "Global Cell Therapy Market, By Use Type, By Therapy Type, By Product, By Technology & By Region- Forecast and Analysis 2022-2028" report has been...
Global Transfection Technologies Market
Outlook on the Transfection Technologies Global Market to 2027 - Increasing Prevalence of Cancer and Various Chronic Lifestyle Diseases is Driving Growth
28 sept. 2022 04h28 HE | Research and Markets
Dublin, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The "Transfection Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Avid Logo June 2022.jpg
Avid Bioservices Appoints Michael Alston, Jr. as Vice President, Operations
22 sept. 2022 08h05 HE | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
BWC-Logo-png.png
Viral Vector Manufacturing Market Tripling Its Size to Cross USD 1.5 Billion by 2028 | BlueWeave Consulting
20 sept. 2022 11h00 HE | BlueWeave Consulting and Research Pvt Ltd
New Delhi, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Global Viral Vector Manufacturing Market is surging at a robust growth rate during the forecast period, mainly due to the efficiency of viral vectors in...
22157.jpg
Global Hemophilia Gene Therapy Market 2022: Featuring BioMarin, Spark, Pfizer, UniQure, Ultragenyx, Shire, Sangamo & Freeline
20 sept. 2022 05h23 HE | Research and Markets
Dublin, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The "Hemophilia Gene Therapy Market, by Hemophilia Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added...
22157.jpg
Worldwide Gene Therapy Industry to 2028 - Increasing Adoption of Gene Therapy for Oncological Disorders Will Provide Growth Opportunities
15 sept. 2022 07h23 HE | Research and Markets
Dublin, Sept. 15, 2022 (GLOBE NEWSWIRE) -- The "Gene Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's...
Avid Logo June 2022.jpg
Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
07 sept. 2022 16h05 HE | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Logo June 2022.jpg
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent Developments
06 sept. 2022 16h05 HE | Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $36.7 Million -- -- Signed $41 Million in Net New Business Orders and Ended the Quarter with a Record High Backlog of $157 Million -- -- Facilities and...